Hepatitis B News and Research

Latest Hepatitis B News and Research

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

A selection of health policy stories from California, New York, Connecticut, Georgia, Indiana and North Carolina.

8 May 2014

MinuteClinic walk-in medical clinics open in central Georgia

The first MinuteClinic walk-in medical clinics in central Georgia have opened inside two CVS/pharmacy stores in Macon and one in Warner Robbins.

7 May 2014

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2014 (1Q14) of $2.35, compared to diluted earnings per common share (EPS) of $2.95 for the quarter ended March 31, 2013 (1Q13).

7 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease.

6 May 2014

Liver cancer screening in cirrhosis patients improves survival rates

Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center.

6 May 2014

Health spending increases hit fastest pace since 1980

USA Today reports on this development, noting some of the factors that will continue to drive up costs. Also, Kaiser Health News explores issues related to who should get costly hepatitis C drugs and The Wall Street Journal reports on the delay in implementing the ICD-10.

6 May 2014

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

Consumption of alcohol has long been associated with an increased risk of advanced liver fibrosis, but a new study published online in Clinical Infectious Diseases from researchers at Penn Medicine and other institutions shows that association is drastically heightened in people co-infected with both HIV and chronic hepatitis C virus (HCV) infection.

5 May 2014

First Edition: May 5, 2014

Today's headlines include reports about how President Barack Obama poked fun at the health law during his White House Correspondents' Dinner speech.

5 May 2014

New webcast for hepatitis receives accreditation by RCN Centre

Roche: The ‘Confronting the silent epidemic: clinical innovation forum’ webcast endorsed by HCV Action, British Liver Trust and the European Liver Patients Association, is now available for healthcare professionals (HCPs) to view on-demand.

5 May 2014

Study: New combination therapy to treat chronic hepatitis C

A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient.

5 May 2014

HealthHIV: Nearly 50% of primary care providers lack knowledge about HIV treatment

Primary care providers who provide clinical HIV care (HIV PCPs) are experiencing rising HIV caseloads from newly insured patients under the Patient Protection and Affordable Care Act (PPACA), according to a national survey released today by HealthHIV.

2 May 2014

Viewpoints: Boehner's 'truthful gaffe' on health law; Larry Kramer's AIDS crusade; costly drugs

Although "repeal and replace" has been the Republican position on Obamacare since 2010, "replace" has been there mainly because it polled well. Republicans were satisfied with the health-care status quo in 2009, and would have been glad to repeal Obamacare to return to it. As Steve Benen points out, Republicans voted for just-plain-repeal many times.

29 Apr 2014

Discovery offers potential target for reversing progression of end-stage liver disease

A team of researchers in the University of Arizona's College of Pharmacy has discovered a molecular pathway that could be key to creating new therapeutics that would slow or even reverse the progression of end-stage liver disease.

26 Apr 2014

Aetna raises earnings outlook

In other market news, coverage continues of the cost and effectiveness of Sovaldi, a new drug to treat hepatitis C, and the related earnings gained by Gilead Sciences, its manufacturer.

25 Apr 2014

First Edition: April 24, 2014

Today's headlines include a number of reports about how the health law is playing in midterm election campaigns.

25 Apr 2014

Sales of hepatitis drug shatter records

Record sales of the pricey new drug, Sovaldi, pushed first-quarter earnings of Gilead Sciences beyond expectations. Meanwhile, Novartis' recently announced deals with GlaxoSmithKline and Eli Lilly show manufacturers' swing towards specialization, reports The Wall Street Journal.

25 Apr 2014

First Edition: April 23, 2014

Today's headlines include a range of health policy news reports, including developments related to the health law, to the marketplace and at the state level.

23 Apr 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.

23 Apr 2014

Cost of Hep C medicines vexing insurers

As health insurance companies reveal much anticipated first-quarter earnings, it's the unpredictable impact from the five-figure cost of new Hepatitis C treatments that are the subject of as much Wall Street worry as the Affordable Care Act.

22 Apr 2014

Hepatitis B News and Research

Latest Hepatitis B News and Research

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

MinuteClinic walk-in medical clinics open in central Georgia

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Liver cancer screening in cirrhosis patients improves survival rates

Health spending increases hit fastest pace since 1980

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

First Edition: May 5, 2014

New webcast for hepatitis receives accreditation by RCN Centre

Study: New combination therapy to treat chronic hepatitis C

HealthHIV: Nearly 50% of primary care providers lack knowledge about HIV treatment

Viewpoints: Boehner's 'truthful gaffe' on health law; Larry Kramer's AIDS crusade; costly drugs

Discovery offers potential target for reversing progression of end-stage liver disease

Aetna raises earnings outlook

First Edition: April 24, 2014

Sales of hepatitis drug shatter records

First Edition: April 23, 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Cost of Hep C medicines vexing insurers

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis B News and Research

Latest Hepatitis B News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in